- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Pricing of orphan drugs across three countries on annual basis 2016
Pricing of orphan drugs across three countries on annual basis 2016
Selected annual-based orphan drug prices compared in UK, U.S., and Australia as of 2016 (in U.S. dollars)*
by Matej Mikulic,
last edited
Nov 20, 2017
This statistic shows the illustrative pricing of three selected orphan drugs across UK, U.S., and Australia, on an annualized basis as of 2016 (in current U.S. dollars). As of that year, the price of Alexion's drug Soliris on an annualized base in the U.S. was 440,000 U.S. dollars, in the UK it was 444,000 U.S. dollars, and it was 500,000 U.S. dollars in Australia.
Selected annual-based orphan drug prices compared in UK, U.S., and Australia as of 2016 (in U.S. dollars)*
Loading statistic...
| Drug (company) | United States | United Kingdom | Australia |
|---|---|---|---|
| Soliris (Alexion) | 440,000 | 444,000 | 500,000 |
| Kalydeco (Vertex) | 306,000 | 267,000 | 300,000 |
| Adcetris (Seattle Generics) | 100,000 | - | 110,000 |
| Drug (company) | United States | United Kingdom | Australia |
|---|---|---|---|
| Soliris (Alexion) | 440,000 | 444,000 | 500,000 |
| Kalydeco (Vertex) | 306,000 | 267,000 | 300,000 |
| Adcetris (Seattle Generics) | 100,000 | - | 110,000 |
© Statista 2019
About this statistic
Source: Torreya Partners
Download
Settings
Share
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by Matej Mikulic,
last edited
Nov 20, 2017
This statistic shows the illustrative pricing of three selected orphan drugs across UK, U.S., and Australia, on an annualized basis as of 2016 (in current U.S. dollars). As of that year, the price of Alexion's drug Soliris on an annualized base in the U.S. was 440,000 U.S. dollars, in the UK it was 444,000 U.S. dollars, and it was 500,000 U.S. dollars in Australia.
- Source
- Torreya Partners
- Show further sources information
- Show publisher information
- Release date
- 2017
- Region
- Worldwide
- Survey time period
- as of October 2017
- Method of interview
- Online survey
- Supplementary notes
- * All values are in current U.S. dollars.
Free access to basic statistics
Source
- Source
- Torreya Partners
- Show further sources information
- Show publisher information
- Release date
- 2017
More information
- Region
- Worldwide
- Survey time period
- as of October 2017
- Method of interview
- Online survey
- Supplementary notes
- * All values are in current U.S. dollars.
Other statistics on the topic
+Pharmaceutical Products & Market
Research and development in European pharmaceutical industry by country 2017
+Pharmaceutical Products & Market
VAT rate on prescription-only drugs in Europe 2018
Pharmaceutical Products & Market
Market share of generics in European countries 2017
+Pharmaceutical Products & Market
Yearly growth rate of R&D spending in pharmaceutical industry 2004-2018
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Statista is a great source of knowledge, and pretty helpful to manage the daily work.Christof Baron
CEO, MindShare Germany
Statistics on "Pharmaceutical trends in Europe"
- Overview
The most important statistics
- Turnover of leading pharmaceutical markets in Europe in 2017 (in million euros)Turnover of leading European pharmaceutical markets 2017
- Turnover of pharmaceutical markets in Central and Eastern Europe in 2017 (in million euros)Turnover of pharmaceutical markets in Central and Eastern Europe 2017
- Share of breakdown of pharmaceutical price structure in Europe in 2016*Pharmaceutical price structure breakdown in Europe 2016
- Value Added Tax (VAT) rate on over-the-counter (OTC) drugs in Europe in 2018, by country*VAT rate on over-the-counter drugs in Europe 2018, by country
- Value Added Tax (VAT) rate on prescription-only drugs in Europe in 2018, by countryVAT rate on prescription-only drugs in Europe 2018
- Share of GDP expenditure on research and development in the EU-28 countries from 2000 to 2017*European Union: share of GDP expenditure on research and development 2000-2017
- Pharmaceutical research and development spending in selected European countries in 2017 (in million euros)Research and development in European pharmaceutical industry by country 2017
- Annual growth of pharmaceutical R&D spending in Europe and the U.S. between 2004 and 2018Yearly growth rate of R&D spending in pharmaceutical industry 2004-2018
- European Pharmaceutical companies
The most important statistics
- Leading 18 European pharmaceutical companies by retail sales in 2018 (in billion U.S. dollars)Leading 18 European pharmaceutical companies by retail sales 2018
- Leading European pharmaceutical companies by spending on research and development in 2018 (in billion U.S. dollars)Leading European pharmaceutical companies by R&D spending 2018
- Pharmaceutical production value of EFPIA members from 1990 to 2018 (in million euros)Members of EFPIA's pharmaceutical production value 1990-2018
- Pharmaceutical research and development spending of EFPIA members from 1990 to 2018 (in million euros)Members of EFPIA's pharmaceutical R&D spending 1990-2018
- Self-medication market
The most important statistics
- Sales in the self-medication market in selected European countries in 2017 (in million euro)Self-medication market sales in Europe in 2017, by country
- Sales of analgesics in the self-medication market in Europe in 2017, by country (in million euro)Self-medication market sales of analgesics in Europe in 2017, by country
- Sales of cough and cold products in the self-medication market in Europe in 2017, by country (in million euro)Cough and cold self-medication market sales in Europe in 2017
- Sales of digestives and intestinal remedies in the self-medication product market in Europe in 2017, by country (in million euro)Digestives and intestinal remedies self-medication market sales in Europe 2017
- Sales of self-medication skin treatment products in Europe in 2017, by country (in million euros)Self-medication skin treatment product sales in Europe 2017, by country
- Sales of vitamin and mineral products in the self medication market in Europe in 2017, by country (in million euro)Self-medication: sales of vitamins and minerals in Europe 2017
- Market value of self-medication drugs in Italy from 2014 to 2017 (in million euros)Italy: market value of self-medication drugs 2014-2017
- Sales revenue of self-care medicines in the Netherlands in 2017, by purchase channel (in million euros)Sales revenue of self-care medicines in the Netherlands 2017, by purchase channel
- Employment
The most important statistics
- Pharmaceutical employment in selected European countries in 2017Employment in European pharmaceutical industry by country 2017
- Total pharmaceutical employment in EFPIA countries from 1990 to 2018Employment in EFPIA pharmaceutical industry 1990-2018
- Employment in pharmaceutical products and preparations manufacturing in the United Kingdom from 2008 to 2017 (in 1,000s)Pharmaceutical manufacturing employment in the United Kingdom 2008-2017
- Number of employees in biotechnology companies, split by private or public sector in Switzerland from 2012 to 2017Switzerland: number of employees in biotech companies 2012-2017
- Number of employees in the pharmaceutical industry in Germany from 2010 to 2016Pharmaceutical industry: number of employees in Germany 2010-2016
- Number of employees in the pharmaceutical industry in Belgium from 2014 to 2017Number of employees in the pharmaceutical industry in Belgium 2014-2017
- Number of employees of pharmaceutical companies in France in 2014, by region of residenceNumber of employees of pharmaceutical companies by region France 2014
- Number of employees in the pharmaceutical industry in Italy between 2000 and 2018Number of employees in the pharmaceutical industry in Italy 2000-2018
- Clinical Trials
The most important statistics
- Distribution of European clinical and phase III pipeline in 2013, by indicationDistribution of European clinical and phase III pipeline 2013 by indication
- Number of clinical trials submitted to the European Medicines Agency from European countries from 2005 to 2011Pivotal trials submitted to the European Medicines Agency from Europe 2005-2011
- Number of patients per clinical trial in selected European countries from 2005 to 2011Patients in clinical trials in selected European countries 2005-2011
- Number of applications to conduct a clinical trial submitted to BfArM and PEI* in Germany from 2009 to 2017Clinical trial conduct applications in Germany 2009-2017
- Number of clinical trials authorized by the competent authority in Italy from 2003 to 2017Italy: number of clinical trials authorized in Italy 2003-2017
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Utilization of orphan drugs in the U.S. by usage type 2014
- Orphan vs. non-orphan drugs median cost per patient per year 2014-2018
- Worldwide Rx drug sales excluding generics and orphan drugs 2002-2024
- Cumulative price change of orphan drugs in the U.S. 2012-2014
- Worldwide share of orphan drug sales by therapy category without oncology 2024
- Orphan drug sales worldwide excluding oncology by therapy category 2024
- Orphan vs. non-orphan pipeline sales forecast worldwide 2019-2024
- Utilization of orphan drugs in the U.S. from 2012 to 2014, by usage type
- Required number of patients for phase III trials of orphan and non-orphan drugs 2015
- Number of orphan drugs used in Sweden 2016-2018
- Number of orphan drugs used in Norway 2016-2018
- Median length of orphan and non-orphan drugs in phase III trial 2015
- Number of cumulative orphan designations accepted in the U.S. 2003-2018
- Number of orphan drugs used in Denmark 2008-2018
- Leading orphan designations in the EU by indication 2015
- Average FDA approved orphan drug sales U.S. 5 years after launch 2014
- Median length of time for orphan and non-orphan drugs for FDA approval 2015
- Italy: consumption of orphan drugs 2017, by ATC
- Italy: expenditure on orphan drugs 2017, by ATC
Statistics on "Pharmaceutical trends in Europe"
- Turnover of leading pharmaceutical markets in Europe in 2017 (in million euros)
- Turnover of pharmaceutical markets in Central and Eastern Europe in 2017 (in million euros)
- Share of breakdown of pharmaceutical price structure in Europe in 2016*
- Value Added Tax (VAT) rate on over-the-counter (OTC) drugs in Europe in 2018, by country*
- Value Added Tax (VAT) rate on prescription-only drugs in Europe in 2018, by country
- Share of GDP expenditure on research and development in the EU-28 countries from 2000 to 2017*
- Pharmaceutical research and development spending in selected European countries in 2017 (in million euros)
- Annual growth of pharmaceutical R&D spending in Europe and the U.S. between 2004 and 2018
- Market share of generics in selected European countries as of 2017
- Leading 18 European pharmaceutical companies by retail sales in 2018 (in billion U.S. dollars)
- Leading European pharmaceutical companies by spending on research and development in 2018 (in billion U.S. dollars)
- Pharmaceutical production value of EFPIA members from 1990 to 2018 (in million euros)
- Pharmaceutical research and development spending of EFPIA members from 1990 to 2018 (in million euros)
- Sales in the self-medication market in selected European countries in 2017 (in million euro)
- Sales of analgesics in the self-medication market in Europe in 2017, by country (in million euro)
- Sales of cough and cold products in the self-medication market in Europe in 2017, by country (in million euro)
- Sales of digestives and intestinal remedies in the self-medication product market in Europe in 2017, by country (in million euro)
- Sales of self-medication skin treatment products in Europe in 2017, by country (in million euros)
- Sales of vitamin and mineral products in the self medication market in Europe in 2017, by country (in million euro)
- Market value of self-medication drugs in Italy from 2014 to 2017 (in million euros)
- Sales revenue of self-care medicines in the Netherlands in 2017, by purchase channel (in million euros)
- Sales revenue of self-care medicines in supermarkets in the Netherlands in 2017, by product segment (in million euros)
- Pharmaceutical employment in selected European countries in 2017
- Total pharmaceutical employment in EFPIA countries from 1990 to 2018
- Employment in pharmaceutical products and preparations manufacturing in the United Kingdom from 2008 to 2017 (in 1,000s)
- Number of employees in biotechnology companies, split by private or public sector in Switzerland from 2012 to 2017
- Number of employees in the pharmaceutical industry in Germany from 2010 to 2016
- Number of employees in the pharmaceutical industry in Belgium from 2014 to 2017
- Number of employees of pharmaceutical companies in France in 2014, by region of residence
- Number of employees in the pharmaceutical industry in Italy between 2000 and 2018
- Distribution of European clinical and phase III pipeline in 2013, by indication
- Number of clinical trials submitted to the European Medicines Agency from European countries from 2005 to 2011
- Number of patients per clinical trial in selected European countries from 2005 to 2011
- Number of applications to conduct a clinical trial submitted to BfArM and PEI* in Germany from 2009 to 2017
- Number of clinical trials authorized by the competent authority in Italy from 2003 to 2017
- Percentage of annual utilization among select orphan drugs in the U.S. in 2014, by usage type
- Median cost per patient per year for orphan and non-orphan drugs from 2014 to 2018 (in U.S. dollars)
- Prescription drugs sales worldwide excluding generics and orphan drugs from 2002 to 2024 (in billion U.S. dollars)
- Percentage cumulative price change among select orphan drugs in the U.S. between 2012 and 2014
- Share of worldwide orphan drug sales without oncology by top therapy category in 2018 and a forecast for 2024
- Worldwide orphan drug sales without oncology by therapy category in 2018 and a forecast for 2024 (in billion U.S. dollars)
- Pipeline sales forecast for orphan and non-orphan drugs worldwide from 2019 to 2024 (in billion U.S. dollars)*
- Percentage of annual utilization among select orphan drugs in the U.S. from 2012 to 2014, by usage type
- Required number of patients for phase III trials of orphan and non-orphan drugs as of 2015*
- Number of orphan drugs used in Sweden from 2016 to 2018
- Number of orphan drugs used in Norway from 2016 to 2018
- Median phase III trial length for orphan and non-orphan drugs as of 2015 (in years)
- Cumulative number of orphan designations in the United States from 2003 to 2018
- Number of orphan drugs used in Denmark from 2008 to 2018
- Number of leading EU orphan designations by indication as of 2015
- Average orphan and non-orphan drug sales in the United States 5 years after launch in 2014*
- Median FDA approval time for orphan and non-orphan drugs as of 2015 (in months)
- Distribution of orphan drugs consumption in Italy in 2017, by ATC*
- Distribution of orphan drugs expenditure in Italy in 2017, by ATC*
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Please log in to access our additional functions
Register in seconds and access exclusive features.
Basic Account
|
Instant Access
Premium Account
| ||
|---|---|---|---|
Our services
Click the question mark for further information | Free |
$49 per month*
| |
| Basic statistics | |||
| Premium statistics | |||
|
Graph download
| |||
| Download PDF | |||
|
Excel download
| |||
| Register | Purchase now | ||
*Duration: 12 months, billed annually, single license
Yes, let me download!
...and make my research life easier.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.